Sihuan Pharmaceutical’s Self-Developed Innovative Oncology Drug Pirotinib Commenced Phase II Clinical Trial in China
Led by Top Oncologist Professor Wu Yilong Expected to Commence Phase III Clinical Trial in 2H2019Demonstrates Strong R&D Capability Soli